Cargando…
Novel variants of CYP21A2 in Vietnamese patients with congenital adrenal hyperplasia
BACKGROUND: Congenital adrenal hyperplasia (CAH) (OMIM #201910) is a complex disease most often caused by pathogenic variant of the CYP21A2 gene. We have designed an efficient multistep approach to diagnose and classify CAH cases due to CYP21A2 variant and to study the genotype‐phenotype relationshi...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503067/ https://www.ncbi.nlm.nih.gov/pubmed/30816000 http://dx.doi.org/10.1002/mgg3.623 |
_version_ | 1783416346548109312 |
---|---|
author | Chi, Dung V. Tran, Thinh H. Nguyen, Duc H. Luong, Long H. Le, Phuong T. Ta, Minh H. Ngo, Huong T. T. Nguyen, Mai P. Le‐Anh, Tuan P. Nguyen, Dat P. Bui, The‐Hung Ta, Van T. Tran, Van K. |
author_facet | Chi, Dung V. Tran, Thinh H. Nguyen, Duc H. Luong, Long H. Le, Phuong T. Ta, Minh H. Ngo, Huong T. T. Nguyen, Mai P. Le‐Anh, Tuan P. Nguyen, Dat P. Bui, The‐Hung Ta, Van T. Tran, Van K. |
author_sort | Chi, Dung V. |
collection | PubMed |
description | BACKGROUND: Congenital adrenal hyperplasia (CAH) (OMIM #201910) is a complex disease most often caused by pathogenic variant of the CYP21A2 gene. We have designed an efficient multistep approach to diagnose and classify CAH cases due to CYP21A2 variant and to study the genotype‐phenotype relationship. METHODS: A large cohort of 212 Vietnamese patients from 204 families was recruited. We utilized Multiplex Ligation‐dependent Probe Amplification to identify large deletion or rearrangement followed by complete gene sequencing of CYP21A2 to map single‐nucleotide changes and possible novel variants. RESULTS: Pathogenic variants were identified in 398 out of 408 alleles (97.5%). The variants indexed span across most of the CYP21A2 gene regions. The most common genotypes were: I2g/I2g (15.35%); Del/Del (14.4%); Del/I2g (10.89%); p.R356W/p.R356W (6.44%); and exon 1–3 del/exon 1–3 del (5.44%). In addition to the previously characterized and documented variants, we also discovered six novel variants which were not previously reported, in silico tools were used to support the pathogenicity of these variants. CONCLUSION: The result will contribute in further understanding the genotype‐phenotype relationship of CAH patients and to guide better treatment and management of the affected. |
format | Online Article Text |
id | pubmed-6503067 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-65030672019-05-10 Novel variants of CYP21A2 in Vietnamese patients with congenital adrenal hyperplasia Chi, Dung V. Tran, Thinh H. Nguyen, Duc H. Luong, Long H. Le, Phuong T. Ta, Minh H. Ngo, Huong T. T. Nguyen, Mai P. Le‐Anh, Tuan P. Nguyen, Dat P. Bui, The‐Hung Ta, Van T. Tran, Van K. Mol Genet Genomic Med Original Articles BACKGROUND: Congenital adrenal hyperplasia (CAH) (OMIM #201910) is a complex disease most often caused by pathogenic variant of the CYP21A2 gene. We have designed an efficient multistep approach to diagnose and classify CAH cases due to CYP21A2 variant and to study the genotype‐phenotype relationship. METHODS: A large cohort of 212 Vietnamese patients from 204 families was recruited. We utilized Multiplex Ligation‐dependent Probe Amplification to identify large deletion or rearrangement followed by complete gene sequencing of CYP21A2 to map single‐nucleotide changes and possible novel variants. RESULTS: Pathogenic variants were identified in 398 out of 408 alleles (97.5%). The variants indexed span across most of the CYP21A2 gene regions. The most common genotypes were: I2g/I2g (15.35%); Del/Del (14.4%); Del/I2g (10.89%); p.R356W/p.R356W (6.44%); and exon 1–3 del/exon 1–3 del (5.44%). In addition to the previously characterized and documented variants, we also discovered six novel variants which were not previously reported, in silico tools were used to support the pathogenicity of these variants. CONCLUSION: The result will contribute in further understanding the genotype‐phenotype relationship of CAH patients and to guide better treatment and management of the affected. John Wiley and Sons Inc. 2019-02-27 /pmc/articles/PMC6503067/ /pubmed/30816000 http://dx.doi.org/10.1002/mgg3.623 Text en © 2019 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals, Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Chi, Dung V. Tran, Thinh H. Nguyen, Duc H. Luong, Long H. Le, Phuong T. Ta, Minh H. Ngo, Huong T. T. Nguyen, Mai P. Le‐Anh, Tuan P. Nguyen, Dat P. Bui, The‐Hung Ta, Van T. Tran, Van K. Novel variants of CYP21A2 in Vietnamese patients with congenital adrenal hyperplasia |
title | Novel variants of CYP21A2 in Vietnamese patients with congenital adrenal hyperplasia |
title_full | Novel variants of CYP21A2 in Vietnamese patients with congenital adrenal hyperplasia |
title_fullStr | Novel variants of CYP21A2 in Vietnamese patients with congenital adrenal hyperplasia |
title_full_unstemmed | Novel variants of CYP21A2 in Vietnamese patients with congenital adrenal hyperplasia |
title_short | Novel variants of CYP21A2 in Vietnamese patients with congenital adrenal hyperplasia |
title_sort | novel variants of cyp21a2 in vietnamese patients with congenital adrenal hyperplasia |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503067/ https://www.ncbi.nlm.nih.gov/pubmed/30816000 http://dx.doi.org/10.1002/mgg3.623 |
work_keys_str_mv | AT chidungv novelvariantsofcyp21a2invietnamesepatientswithcongenitaladrenalhyperplasia AT tranthinhh novelvariantsofcyp21a2invietnamesepatientswithcongenitaladrenalhyperplasia AT nguyenduch novelvariantsofcyp21a2invietnamesepatientswithcongenitaladrenalhyperplasia AT luonglongh novelvariantsofcyp21a2invietnamesepatientswithcongenitaladrenalhyperplasia AT lephuongt novelvariantsofcyp21a2invietnamesepatientswithcongenitaladrenalhyperplasia AT taminhh novelvariantsofcyp21a2invietnamesepatientswithcongenitaladrenalhyperplasia AT ngohuongtt novelvariantsofcyp21a2invietnamesepatientswithcongenitaladrenalhyperplasia AT nguyenmaip novelvariantsofcyp21a2invietnamesepatientswithcongenitaladrenalhyperplasia AT leanhtuanp novelvariantsofcyp21a2invietnamesepatientswithcongenitaladrenalhyperplasia AT nguyendatp novelvariantsofcyp21a2invietnamesepatientswithcongenitaladrenalhyperplasia AT buithehung novelvariantsofcyp21a2invietnamesepatientswithcongenitaladrenalhyperplasia AT tavant novelvariantsofcyp21a2invietnamesepatientswithcongenitaladrenalhyperplasia AT tranvank novelvariantsofcyp21a2invietnamesepatientswithcongenitaladrenalhyperplasia |